Agreed. I think adding a new Matador to Kal's team shows a further commitment towards the Bullrun Mission Statement. I also question whether a merger of Cannabix & Breathtec (pre-product approval) would be feasable and profitable for shareholders? I'm willing to bet there is more shareholders for it versus against it now. Just at what ratio? Personally, I'd say A1 for A1 @ this point.
News 
Market Data 
Discover 
AI
